Caribou Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.41 | -$0.41 | -$0.41 |
| Q2 2024 | 3 | -$0.46 | -$0.46 | -$0.46 |
| Q3 2024 | 5 | -$0.46 | -$0.42 | -$0.45 |
| Q4 2024 | 3 | -$0.46 | -$0.46 | -$0.46 |
| Q1 2025 | 4 | -$0.47 | -$0.47 | -$0.47 |
| Q2 2025 | 4 | -$0.50 | -$0.50 | -$0.50 |
| Q3 2025 | 4 | -$0.53 | -$0.53 | -$0.53 |
| Q4 2025 | 4 | -$0.56 | -$0.56 | -$0.56 |
Caribou Biosciences, Inc. Earnings Date And Information
Caribou Biosciences, Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $-0.42 earnings per share for the quarter, topping analysts' consensus estimates of $-0.45 by $0.03. The company had revenue of 3.46 M for the quarter and had revenue of 34.48 M for the year. Caribou Biosciences, Inc. has generated $-1 earnings per share over the last year ($-1.38 diluted earnings per share) and currently has a price-to-earnings ratio of -1.43. Caribou Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based on prior year's report dates.
Caribou Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2024 | Q2 2024 | -$0.45 | -$0.42 | 0.03 | $3.05 M | $3.46 M |
| 05/07/2024 | Q1 2024 | -$0.39 | -$0.46 | -0.07 | $2.43 M | |
| 03/11/2024 | Q4 2023 | -$0.22 | -$0.39 | -0.17 | $3.56 M | |
| 11/07/2023 | Q3 2023 | -$0.38 | -$0.12 | 0.26 | $3.29 M | $23.66 M |
| 11/17/2023 | Q2 2023 | -$0.48 | $3.08 M | $3.76 M | ||
| 11/17/2023 | Q1 2023 | -$0.41 | $3.50 M | |||
| 03/09/2023 | Q4 2022 | -$0.47 | -$0.44 | 0.03 | $3.69 M | |
| 11/08/2022 | Q3 2022 | -$0.48 | -$0.44 | 0.04 | $3.70 M | $3.30 M |
| 08/09/2022 | Q2 2022 | -$0.37 | -$0.41 | -0.04 | $4.19 M | |
| 05/09/2022 | Q1 2022 | -$0.35 | -$0.29 | 0.06 | $2.66 M | |
| 03/21/2022 | Q4 2021 | -$0.34 | -$0.31 | 0.03 | $4.17 M | $2.56 M |
| 11/09/2021 | Q3 2021 | -$0.12 | -$0.46 | -0.34 | $16.50 M | $3.98 M |
| 09/02/2021 | Q2 2021 | $0.42 | -$0.26 | -0.68 | $16.50 M | $1.48 M |
| 03/30/2021 | Q1 2021 | -$0.48 | $1.59 M | |||
| 12/30/2020 | Q4 2020 | -$0.53 | $984,000 | |||
| 09/29/2020 | Q3 2020 | -$0.29 | $1.20 M | |||
| 06/29/2020 | Q2 2020 | -$0.07 | $8.48 M | |||
| 03/30/2020 | Q1 2020 | -$0.35 | $1.70 M |
Caribou Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Caribou Biosciences, Inc.'s earnings date?
Caribou Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates.
-
Did Caribou Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Caribou Biosciences, Inc. (:CRBU) reported $-0.42 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.45 by $0.03.
-
How can I listen to Caribou Biosciences, Inc.'s earnings conference call?
The conference call for Caribou Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Caribou Biosciences, Inc.'s conference call transcript?
The conference call transcript for Caribou Biosciences, Inc.'s latest earnings report can be read online.
-
How much revenue does Caribou Biosciences, Inc. generate each year?
Caribou Biosciences, Inc. (:CRBU) has a recorded annual revenue of $34.48 M.
-
How much profit does Caribou Biosciences, Inc. generate each year?
Caribou Biosciences, Inc. (:CRBU) has a recorded net income of $34.48 M. Caribou Biosciences, Inc. has generated $-1.38 earnings per share over the last four quarters.
-
What is Caribou Biosciences, Inc.'s price-to-earnings ratio?
Caribou Biosciences, Inc. (:CRBU) has a price-to-earnings ratio of -1.43 and price/earnings-to-growth ratio is -0.09.
